219 related articles for article (PubMed ID: 21459341)
21. [Proposal for a TNM classification of digestive (neuro)endocrine tumors: recommendations of the European Neuroendocrine Tumor Society (2006)].
Couvelard A; Scoazec JY
Ann Pathol; 2006 Dec; 26(6):413-7. PubMed ID: 17255899
[No Abstract] [Full Text] [Related]
22. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
23. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.
Klimstra DS; Modlin IR; Adsay NV; Chetty R; Deshpande V; Gönen M; Jensen RT; Kidd M; Kulke MH; Lloyd RV; Moran C; Moss SF; Oberg K; O'Toole D; Rindi G; Robert ME; Suster S; Tang LH; Tzen CY; Washington MK; Wiedenmann B; Yao J
Am J Surg Pathol; 2010 Mar; 34(3):300-13. PubMed ID: 20118772
[TBL] [Abstract][Full Text] [Related]
24. Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models.
Dolcetta-Capuzzo A; Villa V; Albarello L; Franchi GM; Gemma M; Scavini M; Di Palo S; Orsenigo E; Bosi E; Doglioni C; Manzoni MF
Cancer; 2013 Jan; 119(1):36-44. PubMed ID: 22744914
[TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.
Lim CH; Lee IS; Jun BY; Kim JS; Cho YK; Park JM; Roh SY; Lee MA; Kim SW; Choi MG
Korean J Intern Med; 2017 May; 32(3):452-458. PubMed ID: 28490723
[TBL] [Abstract][Full Text] [Related]
26. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
27. [Classification of gastro-entero-pancreatic neuroendocrine tumors].
Perren A; Schmitt A; Komminoth P; Pavel M
Radiologe; 2009 Mar; 49(3):198-205. PubMed ID: 19224191
[TBL] [Abstract][Full Text] [Related]
28. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
[TBL] [Abstract][Full Text] [Related]
29. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.
Rindi G; Klöppel G; Couvelard A; Komminoth P; Körner M; Lopes JM; McNicol AM; Nilsson O; Perren A; Scarpa A; Scoazec JY; Wiedenmann B
Virchows Arch; 2007 Oct; 451(4):757-62. PubMed ID: 17674042
[TBL] [Abstract][Full Text] [Related]
30. ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors.
Kianmanesh R; Ruszniewski P; Rindi G; Kwekkeboom D; Pape UF; Kulke M; Sevilla Garcia I; Scoazec JY; Nilsson O; Fazio N; Lesurtel M; Chen YJ; Eriksson B; Cioppi F; O'Toole D;
Neuroendocrinology; 2010; 91(4):333-40. PubMed ID: 20424420
[No Abstract] [Full Text] [Related]
31. Professional Practices and Diagnostic Issues in Neuroendocrine Tumour Pathology: Results of a Prospective One-Year Survey among French Pathologists (the PRONET Study).
Scoazec JY; Couvelard A; Monges G; Guyétant S; Bisot-Locard S; Parot X; Lepage C;
Neuroendocrinology; 2017; 105(1):67-76. PubMed ID: 27442514
[TBL] [Abstract][Full Text] [Related]
32. ENETS consensus guidelines for the management of patients with rare metastases from digestive neuroendocrine tumors: rationale and working framework. Introduction.
O'Toole D; Rindi G; Plöckinger U; Wiedenmann B;
Neuroendocrinology; 2010; 91(4):324-5. PubMed ID: 20407213
[No Abstract] [Full Text] [Related]
33. Discrepancies between two alternative staging systems (European Neuroendocrine Tumor Society 2006 and American Joint Committee on Cancer/Union for International Cancer Control 2010) of neuroendocrine neoplasms of the pancreas. A study of 50 cases.
Liszka Ł; Pająk J; Mrowiec S; Zielińska-Pająk E; Gołka D; Lampe P
Pathol Res Pract; 2011 Apr; 207(4):220-4. PubMed ID: 21354717
[TBL] [Abstract][Full Text] [Related]
34. The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.
Figueroa-Vega N; Díaz A; Adrados M; Alvarez-Escolá C; Paniagua A; Aragonés J; Martín-Pérez E; Leskela S; Moreno-Otero R; González-Amaro R; Marazuela M
Endocr Relat Cancer; 2010 Dec; 17(4):897-908. PubMed ID: 20696814
[TBL] [Abstract][Full Text] [Related]
35. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
36. [Ki67 and neuroendocrine tumors].
Couvelard A
Ann Pathol; 2011 Nov; 31(5 Suppl):S55-6. PubMed ID: 22054461
[No Abstract] [Full Text] [Related]
37. [Changes in the concept of neuroendocrine tumor].
Sasano H
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1602-5. PubMed ID: 19838016
[TBL] [Abstract][Full Text] [Related]
38. Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask.
Albertelli M; Grillo F; Lo Calzo F; Puliani G; Rainone C; Colao AAL; Faggiano A;
Front Endocrinol (Lausanne); 2021; 12():680305. PubMed ID: 33967966
[TBL] [Abstract][Full Text] [Related]
39. ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors.
Kos-Kudła B; O'Toole D; Falconi M; Gross D; Klöppel G; Sundin A; Ramage J; Oberg K; Wiedenmann B; Komminoth P; Van Custem E; Mallath M; Papotti M; Caplin M;
Neuroendocrinology; 2010; 91(4):341-50. PubMed ID: 20484875
[No Abstract] [Full Text] [Related]
40. [Gastric neuroendocrine tumors].
Louthan O
Vnitr Lek; 2009 Oct; 55(10):961-6. PubMed ID: 19947241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]